The following presentations were previously broadcast as live webinars and recorded by myMatrixx. They are available to view and download, however, they are not eligible for CE credit.
Urine Drug Testing and Evolving Genetic Screening: Do They Really Impact Outcomes?
The evolving field of genetic testing and opioid therapy will also be explored, including an explanation of how to interpret results from both UDT and genetic tests, along with a practicing physician’s point of view on what these tests mean to an injured patient’s care and outcome.
Understanding Pain Management Requirements
In an effort to tighten controls on prescription drug abuse, physicians must comply with multiple pain management requirements and guidelines. How are physicians adopting these guidelines in their practice and are they working? How does this adoption affect the claims you manage? And what’s new on the legislative horizon?
Don’t Let Non-Healing Fractures Take Control of a Claim
One of the leading injuries resulting in a work comp claim is a broken bone or fracture. Most heal on their own and the normal course of care can be expected, however, what happens when this is not the case? Do you know which of your claimants are high risk for non-healing fractures? What intervention is needed and how can you control costs while getting the injured worker back on the road to recovery? Watch this webcast covering the pro’s and con’s of bone growth stims in the treatment of non-healing fractures.
The Rise of Specialty Drugs in Workers’ Compensation
Twenty years ago there were only ten specialty drugs on the market and they were rarely seen in workers’ compensation. Today there are over 300 and drugs such as anticoagulants and antivirals are making their way into claims. There is a great deal of confusion surrounding specialty drugs. What are they? Why are they so expensive? And will they really impact work comp? One thing is for sure. With a hefty price tag and their potential impact to a claim, they cannot be ignored. This webcast will provide valuable tips for managing specialty drugs in work comp claims.
Strategies for Effective Return to Work Programs
Can injured employees return to work successfully? Yes they can! With a proactive return to work program in place, both the employee and the employer can benefit. This informative discussion on navigating the return to work process was previously broadcast on October 30. View to learn best practices for managing injured employees and getting them back to work safely and quickly.
The Patent Wars: Big Pharma vs. Generics
Big Pharma and generic drug manufacturers have been battling it out in the marketplace and the courtroom for decades, but the intensity of these battles has increased significantly in recent months. As more and more brands are due to come off patent, the big drug companies are utilizing every means possible to delay the release of the generic version. The impact caused by the patent wars to workers’ compensation is staggering. Manufacturers of some of the most expensive brand name drugs in work comp including OxyContin® and Celebrex® continue to delay the release of generic versions. Learn more about this important topic from leading experts in this webinar which previously broadcast on June 6, 2013.
DME Advances and Proper Utilization in Workers’ Compensation
Durable Medical Equipment (DME) is a key component to the care an injured worker receives while they are recovering. The type of DME that is required for a particular patient varies. With so many equipment options and providers to supply them, it can be challenging to know what the injured worker may need. Cost containment can also be a challenging task. In this webinar participants will learn about commonly ordered products and gain valuable insight on billing codes, utilization trends and much more. Length 60 minutes. Previously broadcast on February 26, 2013.
Navigating Medical Marijuana in Workers’ Compensation
Medical marijuana is increasingly being prescribed to treat chronic pain however, does it have a place in workers’ compensation? What are the benefits and what are the risks? Join leading clinical experts from myMatrixx for this informative complimentary webinar and learn more about the pro’s and con’s of using marijuana as a medicine; employer responsibilities and risks; and how to proactively address medical marijuana use as a treatment in workers’ compensation. Length 60 minutes. Previously broadcast on October 26, 2012.
Opioids in the Treatment of Injured Workers: When and How to Maximize Effectiveness
There is no denying the skyrocketing use and cost of pain medications in workers’ compensation. Temporary disability payments are 3.5 times higher when opioids are prescribed and in a recent study many physicians who prescribed narcotics to injured workers were not using the recommended tools to monitor use. Opioids can have a positive effect however, without the proper monitoring to control care and costs, they can wreak havoc. Presenters include Phil Walls, R. Ph., Chief Clinical & Compliance Officer of myMatrixx and Brian S. Downs, Vice President, Quality & Provider Relations of Workers’ Compensation Trust. Length 60 minutes. Previously broadcast on April 4, 2012.
Carrying the Fight Forward
myMatrixx Chief Clinical Officer, Phil Walls, R.Ph. joins an expert panel on some of the new ways the workers’ comp industry is looking to control the use and abuse of narcotics. Areas covered include predictive analytics, urine analysis, behavioral screening and smart pills. Recorded – October 2011.